Partnerships
Infusion first. Then what follows.
We manufacture intravenous solutions. We partner in the hospital therapies that sit beside them. Infusion remains the centre.
The foundation
Infusion therapy
Large-volume crystalloids, small-volume parenterals, ready-to-hang I.V. anti-infectives. Clinically essential fluids, manufactured at Hattar. Everything we build next starts here.
Fields of partnership
Where we look next.
Therapeutic areas we will enter with the right counterpart. The structure follows the medicine.
Cardiometabolic
Hospital medicines for cardiovascular and metabolic care.
Immunology
Biological medicines for immune-mediated disease.
Oncology
Specialty and supportive care around infusion.
Nephrology
Fluid, electrolyte and renal-adjacent therapy.
Critical care & nutrition
Parenteral nutrition and intensive-care fluids.
Infectious disease
Ready-to-hang I.V. anti-infectives — a line we already run.
What a partner inherits
- A DRAP manufacturing licence for I.V. solutions at Hattar.
- Terminal sterilisation in medical-grade polypropylene.
- A hospital infusion channel already in use.
- Further capability is built around the medicine.
What we look for
- Manufacturers who already hold a hospital medicine in a stringent-authority market and want a counterpart here.
- Licence, technology transfer, or equity — the structure follows the medicine.
- A conversation that starts with the dossier and the plant.